Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
40%
Ph phase_2
1
20%
Ph phase_4
1
20%

Phase Distribution

0

Early Stage

1

Mid Stage

1

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
Phase 4Post-market surveillance
1(25.0%)
N/ANon-phased studies
2(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

25.0%

1 of 4 finished

Non-Completion Rate

75.0%

3 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Completed(1)
Terminated(3)
Other(1)

Detailed Status

Withdrawn3
Completed1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (25.0%)
Phase 41 (25.0%)
N/A2 (50.0%)

Trials by Status

completed120%
unknown120%
withdrawn360%

Recent Activity

0 active trials
Showing 5 of 5
withdrawn

Evaluating Ileostomy Hydration Protocol

NCT04669964
unknownnot_applicable

Intravenous Treatments Used in Medication Overuse Headache Bridge Treatment

NCT05608642
completednot_applicable

Subcutaneous vs Intravenous Hydration on Older Adults

NCT03710408
withdrawnphase_4

Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy

NCT01093131
withdrawnphase_2

Abciximab (ReoPro) as a Therapeutic Intervention for Sickle Cell Vaso-Occlusive Pain Crisis

NCT01932554

Clinical Trials (5)

Showing 5 of 5 trials
NCT04669964

Evaluating Ileostomy Hydration Protocol

Withdrawn
NCT05608642Not Applicable

Intravenous Treatments Used in Medication Overuse Headache Bridge Treatment

Unknown
NCT03710408Not Applicable

Subcutaneous vs Intravenous Hydration on Older Adults

Completed
NCT01093131Phase 4

Oral Versus Intravenous Hydration to Prevent Contrast Induced Nephropathy

Withdrawn
NCT01932554Phase 2

Abciximab (ReoPro) as a Therapeutic Intervention for Sickle Cell Vaso-Occlusive Pain Crisis

Withdrawn

All 5 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
5